Expert Review of Gastroenterology & Hepatology, Volume 9, Issue 5 (2015)

Browse this journal
Sample our Medicine, Dentistry, Nursing & Allied Health journals, sign in here to start your FREE access for 14 days

Expert Review of Gastroenterology & Hepatology, Volume 9, Issue 5 (2015)

See all volumes and issues
Vol 18, 2024 Vol 17, 2023 Vol 16, 2022 Vol 15, 2021 Vol 14, 2020 Vol 13, 2019 Vol 12, 2018 Vol 11, 2017 Vol 10, 2016 Volume 9, 2015 Vol 8, 2014 Vol 7, 2013 Vol 6, 2012 Vol 5, 2011 Vol 4, 2010 Vol 3, 2009 Vol 2, 2008 Vol 1, 2007
Download citations Download PDFs Download issue

Editorial

Editorial
Is it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy?
Debbie L Shawcross
Pages: 539-542
Published online: 06 Apr 2015
AbstractforIs it time to target gut dysbiosis and immune dysfunction in the therapy of hepatic encephalopathy? | Full Text | References | PDF (258.7 KB)
  • 2176 Views
  • 23 CrossRef citations
  • 0Altmetric
Free Access
Editorial
Advanced endoscopic therapeutics in Barrett’s neoplasia: where are we now and where are we heading?
Gaius Longcroft-Wheaton & Pradeep Bhandari
Pages: 543-545
Published online: 08 Apr 2015
AbstractforAdvanced endoscopic therapeutics in Barrett’s neoplasia: where are we now and where are we heading? | Full Text | References | PDF (301.1 KB)
  • 552 Views
  • 0 CrossRef citations
  • 0Altmetric
Free Access

Drug Profile

Ritonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy
Samuel W Brayer & K Rajender Reddy
Pages: 547-558
Published online: 06 Apr 2015
AbstractforRitonavir-boosted protease inhibitor based therapy: a new strategy in chronic hepatitis C therapy | Full Text | References | PDF (376.9 KB)
  • 228 Views
  • 23 CrossRef citations
  • 0Altmetric

Special Report

Achieving sustained virological response: what’s the impact on further hepatitis C virus-related disease?
Adriaan J van der Meer
Pages: 559-566
Published online: 12 Jan 2015
AbstractforAchieving sustained virological response: what’s the impact on further hepatitis C virus-related disease? | Full Text | References | PDF (391.4 KB)
  • 278 Views
  • 15 CrossRef citations
  • 0Altmetric
Terminal ileal intubation and biopsy in routine colonoscopy practice
Laura J Neilson, Roisin Bevan, Simon Panter, Siwan Thomas-Gibson & Colin J Rees
Pages: 567-574
Published online: 12 Jan 2015
AbstractforTerminal ileal intubation and biopsy in routine colonoscopy practice | Full Text | References | PDF (219.9 KB)
  • 277 Views
  • 16 CrossRef citations
  • 0Altmetric

Review

Advances in the management of childhood portal hypertension
Patrick McKiernan & Mona Abdel-Hady
Pages: 575-583
Published online: 25 Dec 2014
AbstractforAdvances in the management of childhood portal hypertension | Full Text | References | PDF (258.3 KB)
  • 354 Views
  • 20 CrossRef citations
  • 0Altmetric

Reviews

Novel directions in neoadjuvant therapy for pancreas adenocarcinoma
Andrew Yang & Eileen M O’Reilly
Pages: 585-601
Published online: 16 Feb 2015
AbstractforNovel directions in neoadjuvant therapy for pancreas adenocarcinoma | Full Text | References | PDF (359 KB)
  • 298 Views
  • 3 CrossRef citations
  • 0Altmetric

Review

Role of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications
Stefano Ballestri, Dante Romagnoli, Fabio Nascimbeni, Giampiero Francica & Amedeo Lonardo
Pages: 603-627
Published online: 19 Feb 2015
AbstractforRole of ultrasound in the diagnosis and treatment of nonalcoholic fatty liver disease and its complications | Full Text | References | PDF (1.3 MB)
  • 616 Views
  • 86 CrossRef citations
  • 0Altmetric
Diagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease
Amedeo Lonardo, Stefano Ballestri, Giovanni Targher & Paola Loria
Pages: 629-650
Published online: 20 Oct 2014
AbstractforDiagnosis and management of cardiovascular risk in nonalcoholic fatty liver disease | Full Text | References | PDF (748 KB)
  • 440 Views
  • 65 CrossRef citations
  • 0Altmetric
Fusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening
Andrea Leung, Ho Tsoi & Jun Yu
Pages: 651-657
Published online: 12 Jan 2015
AbstractforFusobacterium and Escherichia: models of colorectal cancer driven by microbiota and the utility of microbiota in colorectal cancer screening | Full Text | References | PDF (385.4 KB)
  • 1076 Views
  • 31 CrossRef citations
  • 0Altmetric
Endoscopic resection of submucosal tumors
Gaius Longcroft-Wheaton & Pradeep Bhandari
Pages: 659-669
Published online: 29 Jan 2015
AbstractforEndoscopic resection of submucosal tumors | Full Text | References | PDF (570 KB)
  • 398 Views
  • 6 CrossRef citations
  • 0Altmetric
Management and diagnosis of fatty liver disease
Amanda Tamar Schneier, Caitlin Colleen Citti & Douglas T Dieterich
Pages: 671-683
Published online: 26 Feb 2015
AbstractforManagement and diagnosis of fatty liver disease | Full Text | References | PDF (852.3 KB)
  • 424 Views
  • 7 CrossRef citations
  • 0Altmetric
Gastroesophageal reflux disease and non-digestive tract diseases
Ying Chen
Pages: 685-692
Published online: 10 Feb 2015
AbstractforGastroesophageal reflux disease and non-digestive tract diseases | Full Text | References | PDF (196.4 KB)
  • 295 Views
  • 5 CrossRef citations
  • 0Altmetric

Original Research

Article
Comparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs
Kristian Thorlund, Eric Druyts, Kabirraaj Toor & Edward J Mills
Pages: 693-700
Published online: 12 Mar 2015
AbstractforComparative efficacy of golimumab, infliximab, and adalimumab for moderately to severely active ulcerative colitis: a network meta-analysis accounting for differences in trial designs | Full Text | References | PDF (435.3 KB) | Supplemental
  • 1159 Views
  • 49 CrossRef citations
  • 0Altmetric
Article
Spontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study)
Fabienne Marcellin, Baptiste Demoulin, Bruno Spire, Marie Suzan-Monti, Perrine Roux, Camelia Protopopescu, Luis Sagaon-Teyssier, Martin Duracinsky, Rosemary Dray-Spira, Maria Patrizia Carrieri & and the ANRS-VESPA2 Study Group
Pages: 701-713
Published online: 27 Feb 2015
AbstractforSpontaneous and post-treatment HCV clearance: relationships with health-related quality of life in HIV infection (ANRS-VESPA2 study) | Full Text | References | PDF (375.2 KB)
  • 112 Views
  • 4 CrossRef citations
  • 0Altmetric

Explore articles

Explore the most recently published articles

Is oncolytic adenoviral-mediated immunotherapy through p53-overexpression the solution to refractory pancreatic ductal adenocarcinoma?
Lucy J.A. Harriss et al.
Review Article | Published online: 31 May 2024
Novel approaches in the medical management of compensated cirrhosis
Antonio Moreno-Loro et al.
Review Article | Published online: 28 May 2024
Endoscopic full thickness resection: techniques, applications, outcomes
Zaheer Nabi et al.
Review Article | Published online: 24 May 2024
Effectiveness of the pharmacological therapy to prevent post ERCP acute pancreatitis: a network meta-analysis
Edgar Julián Rojas-Victoria et al.
Review Article | Published online: 9 May 2024
Open Access
View all latest articles